I-Cheng Lee

8PUBLICATIONS
25CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 26, 2024
Diabetes Mellitus Negatively Impacts Outcomes of HBV-Related Hepatocellular Carcinoma Following Thermal Ablation.

Kuo-Cheng Wu, I-Cheng Lee, Chien-An Liu

|Nov 25, 2024
Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non-Liver Malignancies in Hepatitis B Endemic Areas.

Yi-Ping Hung, Pei-Chang Lee, Yen-Hwa Chang

|Aug 08, 2024
Impact of HCV eradication on recurrence pattern and long-term outcomes in patients with HCV-related hepatocellular carcinoma undergoing radiofrequency ablation.

Kuo-Cheng Wu, I-Cheng Lee, Chen-Ta Chi

|Nov 11, 2022
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment.

I-Cheng Lee, Pei-Chang Lee, Yee Chao

|Oct 14, 2022
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy.

I-Cheng Lee, Keng-Hsin Lan, Chien-Wei Su

|Jul 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai

Pageof 2

Frequent Collaborators

5 joint publications

Yi-Hsiang Huang

3 joint publications

Romeo Kuo-Cheng Wu

3 joint publications

Yee Chao

2 joint publications

Chien-Wei Su